https://investorshangout.com/images/MYImages/80579
Post# of 157744
(Total Views: 839)
Posted On: 05/20/2025 1:31:52 PM
Here is one slide.
Cancer Type
CCR5 H-Score
Urothelial Cancer
183.3
Breast Cancer
164.0
Lung SCC
162.8
Colorectal Cancer
136.0
Lung Adeno
125.1
Pancreatic Cancer
112.9
H&N Cancer
68.4
TNBC (Triple-Negative Breast Cancer)
44.0
Sarcoma
23.6
Colorectal Cancer has a higher CCR5 expression (136.0) than TNBC (44.0), meaning CRC shows more CCR5 overexpression than TNBC in this dataset.
(7)
(0)CytoDyn Inc (CYDY) Stock Research Links
Daniel Rizzo
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://zenodo.org/records/17290045?token=eyJ...UkeT_EvKIQ
— Jeremiah 51:36
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://zenodo.org/records/17290045?token=eyJ...UkeT_EvKIQ
— Jeremiah 51:36